$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] TopicalReview: Levetiracetam in Pediatrics

Journal of child neurology, v.20 no.2, 2005년, pp.87 - 93  

Vigevano, Federico (Neurology Division, Bambino GesU00F9)

Abstract AI-Helper 아이콘AI-Helper

Levetiracetam is a new antiepileptic drug whose efficacy and tolerability are already well known in adults. Few studies are available in children. This review, based on the international literature, aims to identify and make known the possible indications for levetiracetam in childhood. Most studies...

참고문헌 (76)

  1. Klitgaard, Henrik, Matagne, Alain, Gobert, Jean, Wülfert, Ernst. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. European journal of pharmacology, vol.353, no.2, 191-206.

  2. J Neurol Neurosurg Psychiatry Shorvon SD 426 72 2002 10.1136/jnnp.72.1.114 

  3. Gower, A.J., Noyer, M., Verloes, R., Gobert, J., Wulfert, E.. ucb L059, a novel anti-convulsant drug: pharmacological profile in animais. European journal of pharmacology, vol.222, no.2, 193-203.

  4. Loscher, W., Honack, D.. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. European journal of pharmacology, vol.232, no.2, 147-158.

  5. Koskiniemi, M., Van Vleymen, B., Hakamies, L., Lamusuo, S., Taalas, J.. Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo. Journal of neurology, neurosurgery, and psychiatry, vol.64, no.3, 344-348.

  6. Gower, A.T., Hirsch, E., Boehrer, A., Noyer, M., Marescaux, C.. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy research, vol.22, no.3, 207-213.

  7. J Pharmacol Toxicol Cai 241 16 2002 

  8. J Pharmacol Exp Ther Löscher W. 474 284 1998 

  9. Zona, Cristina, Niespodziany, Isabelle, Marchetti, Caterina, Klitgaard, Henrik, Bernardi, Giorgio, Margineanu, Doru Georg. Levetiracetam does not modulate neuronal voltage-gated Na + and T-type Ca 2+ currents. Seizure : European journal of Epilepsy, vol.10, no.4, 279-286.

  10. Epilepsia Modeja M. S19 42 2 2001 

  11. Niespodziany, Isabelle, Klitgaard, Henrik, Margineanu, Doru Georg. Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurones of rat hippocampal slices. Neuroscience letters, vol.306, no.1, 5-8.

  12. Epilepsia Rigo JM S35 41 7 2000 

  13. 10.1046/j.1528-1157.2001.0420s4024.x 

  14. Pellock, John M., Glauser, Tracy A., Bebin, E. Martina, Fountain, Nathan B., Ritter, Frank J., Coupez, René M., Shields, W. Donald. Pharmacokinetic Study of Levetiracetam in Children. Epilepsia : the journal of the International League against Epilepsy, vol.42, no.12, 1574-1579.

  15. Browne, T. R., Szabo, G. K., Leppik, I. E., Josephs, E., Paz, J., Baltes, E., Jensen, C. M.. Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New Technique. The Journal of clinical pharmacology, vol.40, no.6, 590-595.

  16. Levy, R.H., Ragueneau-Majlessi, I., Baltes, E.. Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers. Epilepsy research, vol.46, no.2, 93-99.

  17. Cereghino, J.J., Biton, V., Abou-Khalil, B., Dreifuss, F., Gauer, L.J., Leppik, I.. Levetiracetam for partial seizures : Results of a double-blind, randomized clinical trial. Neurology, vol.55, no.2, 236-242.

  18. Shorvon, Simon D., Löwenthal, Armand, Janz, Dieter, Bielen, Edith, Loiseau, Pierre. Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures. Epilepsia : the journal of the International League against Epilepsy, vol.41, no.9, 1179-1186.

  19. Ben‐Menachem, Elinor, Falter, Ursula. Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating Monotherapy. Epilepsia : the journal of the International League against Epilepsy, vol.41, no.10, 1276-1283.

  20. Epilepsia Folland C. S192 43 7 2002 

  21. Epilepsia Mohanraj R. S196 43 7 2002 

  22. Epilepsia Trinka E. S202 43 7 2002 

  23. 10.1046/j.1528-1157.2001.0420s4031.x 

  24. Grant, R., Shorvon, S.D.. Efficacy and tolerability of 1000–4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy. Epilepsy research, vol.42, no.2, 89-95.

  25. Boon, P, Chauvel, P, Pohlmann-Eden, B, Otoul, C, Wroe, S. Dose–response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy. Epilepsy research, vol.48, no.1, 77-89.

  26. Betts, T, Waegemans, T, Crawford, P. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure : European journal of Epilepsy, vol.9, no.2, 80-87.

  27. van Rijckevorsel, K.. Letter to the Editor: The ‘number needed to treat’ with Levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs). Seizure : European journal of Epilepsy, vol.10, no.3, 235-236.

  28. Epilepsia Gilland E. S190 43 7 2002 

  29. Epilepsia Morrell MJ S197 43 7 2002 

  30. Epilepsia Husain AM S193 43 7 2002 

  31. Epilepsia Fix A. S206 43 7 2002 

  32. Cramer, Joyce A., Menachem, Elinor Ben, French, Jacqueline. Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation. Epilepsy research, vol.47, no.1, 17-25.

  33. Epilepsia Lippmann SM S295 43 7 2002 

  34. Epilepsia Salanova V. S199 43 7 2002 

  35. Epilepsia Mandelbaum DE 182 42 7 2001 

  36. Epilepsia Gustafson MC 55 42 7 2001 

  37. Epilepsia Hovinga C. S213 42 7 2001 

  38. Epilepsia Strunc MJ S92 42 7 2001 

  39. Epilepsia Martland T. S36 43 8 2002 

  40. Epilepsia Veendrick-Meekes M. S37 43 8 2002 

  41. Wheless, James W., Ng, Yu-tze. Levetiracetam in Refractory Pediatric Epilepsy. Journal of child neurology, vol.17, no.6, 413-415.

  42. TAN, MAW J, APPLETON, RICHARD E. Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience. Seizure : European journal of Epilepsy, vol.13, no.3, 142-145.

  43. Epilepsia Faircloth VC S54 42 7 2001 

  44. Glauser, Tracy A., Pellock, John M., Bebin, E. Martina, Fountain, Nathan B., Ritter, Frank J., Jensen, Christof M., Shields, W. Donald. Efficacy and Safety of Levetiracetam in Children with Partial Seizures: An Open-label Trial. Epilepsia : the journal of the International League against Epilepsy, vol.43, no.5, 518-524.

  45. Epilepsia Bourgeois Bfd 53 42 7 2001 

  46. Epilepsia Frost MD S57 43 7 2002 

  47. Epilepsia Koukkari MW S194 43 7 2002 

  48. Epilepsia Aylett SE S181 43 8 2002 

  49. Marson, A.G, Hutton, J.L, Leach, J.P, Castillo, S, Schmidt, D, White, S, Chaisewikul, R, Privitera, M, Chadwick, D.W. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy research, vol.46, no.3, 259-270.

  50. Epilepsia Mushtaq R. S107 43 7 2002 

  51. Epilepsia Lindholm D. S60 43 7 2002 

  52. Kasteleijn-Nolst Trenité, D.G.A., Marescaux, C., Stodieck, S., Edelbroek, P.M., Oosting, J.. Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam. Epilepsy research, vol.25, no.3, 225-230.

  53. Epilepsia Covanis A. S80 44 8 2003 

  54. Genton, Pierre, Gélisse, Philippe. Antimyoclonic effect of levetiracetam. Epileptic disorders : international epilepsy journal with videotape, vol.2, no.4, 209-212.

  55. Krauss, G.L., Bergin, A., Kramer, R.E., Cho, Y.-W., Reich, S.G.. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology, vol.56, no.3, 411-412.

  56. Frucht, Steven J., Louis, Elan D., Chuang, Cathy, Fahn, Stanley. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology, vol.57, no.6, 1112-1114.

  57. Genton, Pierre, Gelisse, Philippe. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology, vol.57, no.6, 1144-1145.

  58. Schauer, Robert, Singer, Markus, Saltuari, Leopold, Kofler, Markus. Suppression of cortical myoclonus by levetiracetam. Movement disorders : official journal of the Movement Disorder Society, vol.17, no.2, 411-415.

  59. Epilepsia Mathews G. S114 44 8 2003 

  60. Neurology Resor SR S294 58 3 2002 

  61. Epilepsia Jongsma M. S153 43 8 2002 

  62. Epilepsia Meencke H. S153 43 8 2002 

  63. Epilepsia Hirsch E. S187 43 7 2002 

  64. COHEN, JEFFREY. Levetiracetam monotherapy for primary generalised epilepsy. Seizure : European journal of Epilepsy, vol.12, no.3, 150-153.

  65. Epilepsia Berg J. S79 44 8 2003 

  66. BELLO-ESPINOSA, LUIS E, ROBERTS, SUMMER L. Levetiracetam for benign epilepsy of childhood with centrotemporal spikes—three cases. Seizure : European journal of Epilepsy, vol.12, no.3, 157-159.

  67. Epilepsia Barron TF 53 42 7 2001 

  68. Ann Neurol de los Reyes EC S108 50 1 2001 10.1002/ana.1076 

  69. Epilepsia Buyse G. S154 43 8 2002 

  70. Epilepsia Kugler SL S59 43 7 2002 

  71. Kossoff, Eric H., Bergey, Gregory K., Freeman, John M., Vining, Eileen P. G.. Levetiracetam Psychosis in Children with Epilepsy. Epilepsia : the journal of the International League against Epilepsy, vol.42, no.12, 1611-1613.

  72. Epilepsia Gustafson MC S58 43 7 2002 

  73. Epilepsia Miller GS S62 43 7 2002 

  74. Epilepsia Wannag E. 57 42 7 2001 

  75. Epilepsia Johannessen S. S150 43 8 2002 

  76. Epileptic Disord Glauser TA S45 5 1 2003 10.1684/j.1950-6945.2003.tb00526.x 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로